DELTAGEN PROTEOMICS INC has a total of 18 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SYNAPTIC RES LLC, FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST BIOORGANICHESKOJ KHIMII IM AKADEMIKOV and SHANGHAI CELL THERAPY GROUP CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Canada | 2 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations | |
#5 | Analysing materials | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kamb Carl Alexander | 17 |
#2 | Caponigro Giordano Michael | 4 |
#3 | Richards Burt Timothy | 4 |
#4 | Karpilow Jon | 4 |
#5 | Poritz Mark Aaron | 2 |
#6 | Teng David Heng-Fai | 2 |
#7 | Abedi Majid | 1 |
Publication | Filing date | Title |
---|---|---|
AU2003256572A1 | Negative selections assays, and compositions thereof | |
WO03008648A1 | Methods for identifying agents that induce a cellular phenotype, and compositions thereof | |
EP1407045A2 | Retinoid pathway assays, and compositions therefrom | |
AU2002236451A1 | Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens | |
US6582899B1 | Methods for identifying agents that cause a lethal phenotype, and agents thereof |